Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « ISSN » - entrée « 1468-2060 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1468-201X < 1468-2060 < 1468-2079  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 78.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000093 (2021) Hercílio Martelli Júnior ; Nelson Pereira Marques ; Nádia Carolina Teixeira Marques ; Edson Gomes De Lucena ; Daniella Reis B. Martelli ; Eduardo A. OliveiraCorrespondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
000343 (2021) Alessia Alunno ; Aurélie Najm ; Xavier Mariette ; Gabriele De Marco ; Jenny Emmel ; Laura Mason ; Dennis G. Mcgonagle ; Pedro M. MachadoImmunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider.
000478 (2021) Sarthak Gupta ; Shuichiro Nakabo ; Jun Chu ; Sarfaraz Hasni ; Mariana J. KaplanCorrespondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
000771 (2020) Alexis Mathian ; Zahir AmouraResponse to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al' by Notz et al.
000A38 (2021) Kim Lauper ; Johannes W J. Bijlsma ; Gerd R. BurmesterTrajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.
000C72 (2020) Alexis Mathian ; Zahir AmouraResponse to: 'Implications of SARS-CoV-2 infection for patients with rheumatic disease' by Lin et al.
000C96 (2020) Alexis Mathian ; Zahir AmouraResponse to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah et al.
000D56 (2020) Emilie Sbidian ; Laetitia Penso ; Philippe Herlemont ; Jérémie Botton ; Bérangère Baricault ; Laura Semenzato ; Jérome Drouin ; Alain Weill ; Rosemay Dray-Spira ; Mahmoud ZureikComment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
000D57 (2020) Quirin Notz ; Patrick Meybohm ; Peter Kranke ; Dirk Weismann ; Christopher Lotz ; Marc SchmalzingAntirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian et al.
000E87 (2020) Jose L. Pablos ; María Galindo ; Loreto Carmona ; Ana Lled ; Miriam Retuerto ; Ricardo Blanco ; Miguel A. Gonzalez-Gay ; David Martinez-Lopez ; Isabel Castrej N ; José M. Alvaro-Gracia ; David Fernández Fernández ; Antonio Mera-Varela ; Sara Manrique-Arija ; Natalia Mena Vázquez ; Antonio Fernandez-NebroClinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
000E92 (2020) Changsong Lin ; Ziyu Wang ; Jie Li ; Xinyi Xia ; Yun Liu ; Qianghu WangImplications of SARS-CoV-2 infection for patients with rheumatic disease.
000F41 (2020) Chien Hsien Lo ; Yu-Hsun Wang ; Chin Feng Tsai ; Kuei Chuan Chan ; Li Ching Li ; Tse Hsien Lo ; Chun Hung Su ; James Cheng-Chung WeiCorrespondence on 'Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist' by Graef et al.
000F42 (2020) Ali Duarte-García ; Elizabeth R. Graef ; Jean W. Liew ; Maximilian F. Konig ; Alfred Hyoungju Kim ; Jeffrey A. SparksResponse to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.
000F66 (2020) Mendel E. Singer ; David C. Kaelber ; Maria J. AntonelliHydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis.
000F67 (2021) Kevin L. Winthrop ; Amanda E. Brunton ; Susan Beekmann ; Philip Polgreen ; John Baddley ; Kenneth G. Saag ; Cassandra Calabrese ; Leonard Calabrese ; Philip C. Robinson ; Zachary S. Wallace ; Jeffrey R. CurtisSARS CoV-2 infection among patients using immunomodulatory therapies.
000F68 (2020) Manuel Francisco Ugarte-Gil ; Maximilian F. Konig ; Peter Korsten ; Francis Berenbaum ; Alfred Hyoungju Kim ; Jeffrey A. SparksResponse to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al.
000F69 (2020) Alexis Mathian ; Zahir AmouraResponse to: 'Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al.
000F84 (2020) Alexis Mathian ; Marc Pineton De Chambrun ; Alain Combes ; Zahir AmouraResponse to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al.
001021 (2020) Cheng Lay Teh ; Yaw Kiet Cheong ; Wan Rosmaiza Wan Musa ; Sharifah Aishah Wan Mohd Akbar ; Noraini Mat Husin ; Suk Chyn GunCOVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.
001022 (2020) Alexis Mathian ; Zahir AmouraResponse to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al.
001031 (2020) Mirko Scarsi ; Silvia Piantoni ; Enrico Colombo ; Paolo Air ; Donata Richini ; Marco Miclini ; Valeria Bertasi ; Marta Bianchi ; Damiano Bottone ; Patrizia Civelli ; Maria-Sofia Cotelli ; Ezio Damiolini ; Gloria Galbassini ; Diego Gatta ; Maria-Laura Ghirardelli ; Roberto Magri ; Paola Malamani ; Monia Mendeni ; Stefano Molinari ; Andrea Morotti ; Luisa Salada ; Marinella Turla ; Angiola Vender ; Angela Tincani ; Antonio Brucato ; Franco Franceschini ; Roberto Furloni ; Laura AndreoliAssociation between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "1468-2060" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "1468-2060" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1468-2060
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021